BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Intellia Therapeutics Inc. (NASDAQ:NTLA)

1 post

Biotech NewsForget Daily Pills—Intellia Therapeutics (NTLA) is Creating Cures You Only Need Once

  • BioTech Health X
  • July 1, 2025
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a biotechnology company at the forefront of a genomic revolution, pioneering the development…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Axsome (AXSM) Posts $150M Q2 Revenue, Beats EPS Expectations
  • REGENXBIO (RGNX) Reports $89M Revenue, $6.1M Profit in Q1 2025
  • Avalo Therapeutics (AVTX) Surges 45% in 6 Months
  • CERO Stock Price Targets $45—But Reality Sits at $6.93
  • Long COVID Patients Report 90% Fatigue Reversal After PridCor Therapy
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • September 5, 2025
    Axsome (AXSM) Posts $150M Q2 Revenue, Beats EPS Expectations
    • September 5, 2025
    REGENXBIO (RGNX) Reports $89M Revenue, $6.1M Profit in Q1 2025
    • September 5, 2025
    Avalo Therapeutics (AVTX) Surges 45% in 6 Months
    • September 5, 2025
    CERO Stock Price Targets $45—But Reality Sits at $6.93
    • September 4, 2025
    Long COVID Patients Report 90% Fatigue Reversal After PridCor Therapy
Recent Posts
  • Oscar Health (OSCR) Revenue Hits $5.91B in First Half 2025 – Up 35.5%
    • September 4, 2025
  • Aurinia Pharmaceuticals (AUPH) Hits 52-Week High
    • September 4, 2025
  • Personalis (PSNL) s Beating the Odds – And It Could Beat Cancer Too
    • September 4, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (367)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top